• 09: Interferon-γ Release Assays for TB in Cancer Patients

  • Jan 30 2025
  • Durée: 14 min
  • Podcast

09: Interferon-γ Release Assays for TB in Cancer Patients

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • This research article retrospectively analyzes interferon-gamma release assay (IGRA) test results (QuantiFERON-TB and T-SPOT.TB) from cancer patients to determine their effectiveness in diagnosing tuberculosis (TB). The study at a major US cancer center found T-SPOT.TB yielded significantly more actionable results than QFT-TB, with QFT-TB producing a high rate of indeterminate results. Several factors, including immunosuppressant use and low hemoglobin, were associated with IGRA test invalidity or indeterminacy. While T-SPOT.TB showed better diagnostic performance for latent TB infection, the low TB disease prevalence limited conclusions on its ability to predict progression to active disease. The findings highlight the need for improved diagnostic tools for TB in immunocompromised individuals.


    Batista MV, Sassine J, Khawaja F, et al. The Utility of Interferon-γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transpl Infect Dis 2024;e14428.

    PMID: 39731624


    Created with NotebookLM by Google so there may be mistakes and/or errors.
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de 09: Interferon-γ Release Assays for TB in Cancer Patients

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.